Print

Labtec GmbH and GlaxoSmithKline (GSK) Finalize License Agreement  
6/21/2010 8:06:00 AM

LANGENFELD/RHEINLAND, Germany--(BUSINESS WIRE)--In a recently finalized license agreement, the Consumer Healthcare division of GlaxoSmithKline acquired the exclusive marketing rights for a new topical patch for the treatment of cold sores from Labtec GmbH, the transdermal and topical patch specialist based in Langenfeld, Germany. The agreement designates Labtec as the exclusive manufacturer.
//-->